These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24006947)

  • 1. Type I IFN exhaustion is a host defence protecting against secondary bacterial infections.
    Furuya Y; Müllbacher A
    Scand J Immunol; 2013 Nov; 78(5):395-400. PubMed ID: 24006947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interferon response to bacterial and viral infections.
    Pietras EM; Saha SK; Cheng G
    J Endotoxin Res; 2006; 12(4):246-50. PubMed ID: 16953977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Type I Interferon in Co-infections With Parasites and Viruses, Bacteria, or Other Parasites.
    Ma Y; Su XZ; Lu F
    Front Immunol; 2020; 11():1805. PubMed ID: 33193291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-promoting effects of type I interferons in viral, bacterial, and coinfections.
    Davidson S; Maini MK; Wack A
    J Interferon Cytokine Res; 2015 Apr; 35(4):252-64. PubMed ID: 25714109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaustion of type I interferon response following an acute viral infection.
    Alsharifi M; Regner M; Blanden R; Lobigs M; Lee E; Koskinen A; Müllbacher A
    J Immunol; 2006 Sep; 177(5):3235-41. PubMed ID: 16920963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective role of endogenous interferon in viral, bacterial, and protozoal infections.
    Baron S; Weigent D; Stanton GJ; Peterson J
    Antiviral Res; 1985; Suppl 1():173-83. PubMed ID: 3936412
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon type I responses in primary and secondary infections.
    Alsharifi M; Müllbacher A; Regner M
    Immunol Cell Biol; 2008; 86(3):239-45. PubMed ID: 18180794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection.
    Alsharifi M; Lobigs M; Regner M; Lee E; Koskinen A; Müllbacher A
    J Immunol; 2005 Oct; 175(7):4635-40. PubMed ID: 16177109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.
    Ng CT; Mendoza JL; Garcia KC; Oldstone MB
    Cell; 2016 Jan; 164(3):349-52. PubMed ID: 26824652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon: friend or foe?
    Trinchieri G
    J Exp Med; 2010 Sep; 207(10):2053-63. PubMed ID: 20837696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons in infectious disease.
    McNab F; Mayer-Barber K; Sher A; Wack A; O'Garra A
    Nat Rev Immunol; 2015 Feb; 15(2):87-103. PubMed ID: 25614319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection.
    Malireddi RK; Kanneganti TD
    Front Cell Infect Microbiol; 2013; 3():77. PubMed ID: 24273750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Virus Infection in Deregulating the Cytokine Response to Secondary Bacterial Infection.
    Mehta D; Petes C; Gee K; Basta S
    J Interferon Cytokine Res; 2015 Dec; 35(12):925-34. PubMed ID: 26308503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early IFN type I response: Learning from microbial evasion strategies.
    Coccia EM; Battistini A
    Semin Immunol; 2015 Mar; 27(2):85-101. PubMed ID: 25869307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune defence in mice lacking type I and/or type II interferon receptors.
    van den Broek MF; Müller U; Huang S; Zinkernagel RM; Aguet M
    Immunol Rev; 1995 Dec; 148():5-18. PubMed ID: 8825279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
    Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.
    Rossi M; Castiglioni P; Hartley MA; Eren RO; Prével F; Desponds C; Utzschneider DT; Zehn D; Cusi MG; Kuhlmann FM; Beverley SM; Ronet C; Fasel N
    Proc Natl Acad Sci U S A; 2017 May; 114(19):4987-4992. PubMed ID: 28439019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of type I interferons in CD4
    Kuka M; De Giovanni M; Iannacone M
    Immunol Lett; 2019 Nov; 215():19-23. PubMed ID: 30771379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection.
    Roberts S; Salmon SL; Steiner DJ; Williams CM; Metzger DW; Furuya Y
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells and interferons.
    Paolini R; Bernardini G; Molfetta R; Santoni A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):113-20. PubMed ID: 25443799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.